Holen Sie sich die Stockscreener-App
33.34
2.68%
0.87
Handel nachbörslich:
33.50
0.16
+0.48%
Schlusskurs vom Vortag:
$32.47
Offen:
$32.97
24-Stunden-Volumen:
947.26K
Relative Volume:
0.75
Marktkapitalisierung:
$1.66B
Einnahmen:
$239.44M
Nettoeinkommen (Verlust:
$-80.45M
KGV:
-20.45
EPS:
-1.6303
Netto-Cashflow:
$-40.05M
1W Leistung:
+2.27%
1M Leistung:
+29.88%
6M Leistung:
+28.08%
1J Leistung:
+78.48%
1-Tages-Spanne:
$32.94
$33.86
1-Wochen-Bereich:
$32.25
$33.86
52-Wochen-Spanne:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
33.34 | 1.62B | 239.44M | -80.45M | -40.05M | -1.6303 |
ISRG
Intuitive Surgical Inc
|
436.64 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.70 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
207.98 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | Eingeleitet | Wedbush | Neutral |
| 2026-01-16 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
What's Driving Broadwood Partners' Deep Dive into STAAR Surgical - Kavout
Midday Stock Roundup: Glaukos Corp. Shares Drop 11% - Orange County Business Journal
5 must-read analyst questions from STAAR Surgical’s Q1 earnings call - MSN
Vision-correction lens maker STAAR hosts May investor talks - Stock Titan
STAAR Surgical Announces Participation in Upcoming Investor Conferences - Yahoo Finance
5 Must-Read Analyst Questions From STAAR Surgical’s Q1 Earnings Call - Yahoo Finance
STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1 - Investing.com Nigeria
STAAR Surgical (STAA) Q1 2026 Earnings Transcript - AOL.com
STAAR Surgical Q1 2026 Results: Revenue Up 120%, EPS Beats EstimatesNews and Statistics - IndexBox
STAAR Surgical (STAA) interim Co-CEO receives PSUs and share tax withholding - Stock Titan
STAAR Surgical (STAA) interim co-CEO reports PSU vesting and tax withholding - Stock Titan
STAAR Surgical (STAA) CDO logs PSU vesting, tax-withheld shares and new holdings - Stock Titan
STAA Q1 Deep Dive: China Momentum, Cost Discipline, and Stabilized Inventory Drive Turnaround - Yahoo Finance
GABELLI & Co INVESTMENT ADVISERS INC. Sells 40,000 Shares of STAAR Surgical Company $STAA - MarketBeat
Why did STAAR Surgical (STAA) stock jump 20% after hours? - MSN
STAAR Surgical Q1 earnings call highlights - MSN
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
STAAR Surgical Co stock (US8577001096): Q1 earnings beat and rating upgrade put focus back on growth - AD HOC NEWS
Is Staar Surgical (STAA) Overvalued After Q1 2026 Earnings Beat? - GuruFocus
STAAR Surgical (NASDAQ:STAA) Upgraded at Wall Street Zen - MarketBeat
STAA Maintained by Wells Fargo -- Price Target Raised to $25.00 - GuruFocus
STAAR targets about 75% gross margin and $225M 2026 spend as Switzerland plans to supply 100% of China lenses - MSN
STAAR Surgical Company (NASDAQ:STAA) Q1 2026 Earnings Call Transcript - Insider Monkey
Staar Surgical Company stock hits 52-week high at 35.7 USD - Investing.com Canada
A Look at Staar Surgical Co (STAA) After 8.9% Gain -- GF Value $29.35 vs Price $32.01 - GuruFocus
STAAR Surgical (STAA) Sees Record Q1 Growth, Analysts Boost Pric - GuruFocus
STAA Maintained by Canaccord Genuity -- Price Target Raised to $32 - GuruFocus
STAA Maintained by Stifel -- Price Target Raised to $31.00 - GuruFocus
STAAR Surgical (STAA) Stock Soars 10% After Impressive Q1 Earnin - GuruFocus
STAA Maintains Rating by Mizuho -- Price Target Raised to $27.00 - GuruFocus
STAA Upgraded by Wedbush -- Price Target Raised to $40 - GuruFocus
STAA stock on track for its fourth straight session of gains – this analyst would rather be early than late on STAAR’s growth story - MSN
STAA Rated Neutral by Piper Sandler -- Price Target Raised to $3 - GuruFocus
Earnings To Watch: STAAR Surgical (STAA) Reports Q1 Results Tomorrow - Yahoo Finance UK
Why is STAAR Surgical stock surging today? By Investing.com - Investing.com Australia
Staar Surgical (STAA) Sees Upgrade to Outperform with Target Pri - GuruFocus
Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On Thursday - Benzinga
Why is STAAR Surgical stock surging today? - Investing.com
Piper Sandler raises STAAR Surgical stock price target on Q1 beat - Investing.com Nigeria
Piper Sandler raises STAAR Surgical stock price target on Q1 beat By Investing.com - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Given New $27.00 Price Target at Mizuho - MarketBeat
STAAR Surgical net sales up 119.6% to USD 93.5M in Q1 2026 - Medical Buyer
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Staar Surgical Co-Aktie (STAA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 09 '26 |
Buy |
22.05 |
27,485 |
606,138 |
15,453,629 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 06 '26 |
Buy |
21.62 |
336,946 |
7,284,281 |
15,356,437 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 07 '26 |
Buy |
22.00 |
66,467 |
1,462,301 |
15,422,904 |
1.04%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):